공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 안검염 치료제 시장(2021-2025년)

Global Blepharitis Drugs Market 2021-2025

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2021년 02월 상품 코드 987825
페이지 정보 영문 120 Pages
가격
US $ 2,500 ₩ 2,825,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,390,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,521,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,651,000 PDF (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 안검염 치료제 시장(2021-2025년) Global Blepharitis Drugs Market 2021-2025
발행일 : 2021년 02월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 안검염 치료제 시장 규모는 2021-2025년간 3억 5,538만 달러 성장할 전망이며, 예측기간 중 연평균 복합 성장률(CAGR)은 5%를 나타낼 것으로 예측됩니다. 안검염에 대한 복합 약물 및 고위험요인의 사용이 증가함에 따라 시장 성장이 가속화하고 있습니다.

세계의 안검염 치료제(Blepharitis Drugs) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인 및 저해요인 분석, 제품별·지역별 시장 규모 추이와 예측, 벤더 분석, 시장 기회 등의 정보를 제공합니다.

목차

개요

시장 구도

시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2020년)
  • 시장 전망 : 예측(2020-2025년)

Five Forces 분석

제품별 시장 세분화

  • 시장 부문
  • 제품별 비교
  • 스테로이드 - 시장 규모와 예측(2020-2025년)
  • 항생제 - 시장 규모와 예측(2020-2025년)
  • 제품별 시장 기회

고객 상황

지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 - 시장 규모와 예측(2020-2025년)
  • 유럽 - 시장 규모와 예측(2020-2025년)
  • 아시아 - 시장 규모와 예측(2020-2025년)
  • 기타 지역 - 시장 규모와 예측(2020-2025년)
  • 주요 국가
  • 지역 시장 기회
  • 시장 추진력
  • 시장이 해결해야 할 과제
  • 시장 동향

벤더 구도

  • 경쟁 시나리오
  • 벤더 구도
  • 창조적 파괴 상황

벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • AbbVie Inc.
  • Akorn Inc.
  • Alembic Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Santen Pharmaceutical Co. Ltd.

부록

LSH 21.02.18

Technavio has been monitoring the blepharitis drugs market and it is poised to grow by $ 355.38 mn during 2021-2025 progressing at a CAGR of 5% during the forecast period. Our report on blepharitis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing use of combination drugs and high-risk factors for blepharitis. In addition, increasing use of combination drugs is anticipated to boost the growth of the market as well.

The blepharitis drugs market analysis includes product segment and geographical landscapes.

Technavio's blepharitis drugs market is segmented as below:

By Product

  • Steroids
  • Antibiotics

By Geographical Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing awareness about eye diseases as one of the prime reasons driving the blepharitis drugs market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on blepharitis drugs market covers the following areas:

  • Blepharitis drugs market sizing
  • Blepharitis drugs market forecast
  • Blepharitis drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blepharitis drugs market vendors that include AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Bausch Health Companies Inc., Bayer AG, GlaxoSmithKline Plc, Novartis AG, Pfizer Inc., Sanofi, and Santen Pharmaceutical Co. Ltd.. Also, the blepharitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Steroids - Market size and forecast 2020-2025
  • Antibiotics - Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Competitive scenario
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Akorn Inc.
  • Alembic Pharmaceuticals Ltd.
  • Bausch Health Companies Inc.
  • Bayer AG
  • GlaxoSmithKline Plc
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Santen Pharmaceutical Co. Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Product - Market share 2020-2025 (%)
  • 22: Comparison by Product
  • 23: Steroids - Market size and forecast 2020-2025 ($ million)
  • 24: Steroids - Year-over-year growth 2020-2025 (%)
  • 25: Antibiotics - Market size and forecast 2020-2025 ($ million)
  • 26: Antibiotics - Year-over-year growth 2020-2025 (%)
  • 27: Market opportunity by Product
  • 28: Customer landscape
  • 29: Market share by geography 2020-2025 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2020-2025 ($ million)
  • 32: North America - Year-over-year growth 2020-2025 (%)
  • 33: Europe - Market size and forecast 2020-2025 ($ million)
  • 34: Europe - Year-over-year growth 2020-2025 (%)
  • 35: Asia - Market size and forecast 2020-2025 ($ million)
  • 36: Asia - Year-over-year growth 2020-2025 (%)
  • 37: ROW - Market size and forecast 2020-2025 ($ million)
  • 38: ROW - Year-over-year growth 2020-2025 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: AbbVie Inc. - Overview
  • 48: AbbVie Inc. - Business segments
  • 49: AbbVie Inc. - Key offerings
  • 50: AbbVie Inc. - Key customers
  • 51: AbbVie Inc. - Segment focus
  • 52: Akorn Inc. - Overview
  • 53: Akorn Inc. - Product and service
  • 54: Akorn Inc. - Key offerings
  • 55: Akorn Inc. - Key customers
  • 56: Akorn Inc. - Segment focus
  • 57: Alembic Pharmaceuticals Ltd. - Overview
  • 58: Alembic Pharmaceuticals Ltd. - Product and service
  • 59: Alembic Pharmaceuticals Ltd. - Key offerings
  • 60: Alembic Pharmaceuticals Ltd. - Key customers
  • 61: Alembic Pharmaceuticals Ltd. - Segment focus
  • 62: Bausch Health Companies Inc. - Overview
  • 63: Bausch Health Companies Inc. - Business segments
  • 64: Bausch Health Companies Inc. - Key offerings
  • 65: Bausch Health Companies Inc. - Key customers
  • 66: Bausch Health Companies Inc. - Segment focus
  • 67: Bayer AG - Overview
  • 68: Bayer AG - Business segments
  • 69: Bayer AG - Key offerings
  • 70: Bayer AG - Key customers
  • 71: Bayer AG - Segment focus
  • 72: GlaxoSmithKline Plc - Overview
  • 73: GlaxoSmithKline Plc - Business segments
  • 74: GlaxoSmithKline Plc - Key offerings
  • 75: GlaxoSmithKline Plc - Key customers
  • 76: GlaxoSmithKline Plc - Segment focus
  • 77: Novartis AG - Overview
  • 78: Novartis AG - Business segments
  • 79: Novartis AG - Key offerings
  • 80: Novartis AG - Key customers
  • 81: Novartis AG - Segment focus
  • 82: Pfizer Inc. - Overview
  • 83: Pfizer Inc. - Business segments
  • 84: Pfizer Inc. - Key offerings
  • 85: Pfizer Inc. - Key customers
  • 86: Pfizer Inc. - Segment focus
  • 87: Sanofi - Overview
  • 88: Sanofi - Business segments
  • 89: Sanofi - Key offerings
  • 90: Sanofi - Key customers
  • 91: Sanofi - Segment focus
  • 92: Santen Pharmaceutical Co. Ltd. - Overview
  • 93: Santen Pharmaceutical Co. Ltd. - Business segments
  • 94: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 95: Santen Pharmaceutical Co. Ltd. - Key customers
  • 96: Santen Pharmaceutical Co. Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations
Back to Top
전화 문의
F A Q